findmyKOL
Clinical trialNCT03703856CompletedPhase 4Interventional

Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease

SponsorUniversity of California, San DiegoEnrollment53Alzheimer Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The effects of the medication, memantine, on brain functions and the symptoms of Alzheimer's Disease will be tested
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Clinical Teaching Facility (ctf-B102) at Ucsd Medical Center

    San Diego, California, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Memantine →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2019
Primary completion
8 Jan 2025
Completion
30 Dec 2025
Last update posted
16 Apr 2026
Registered enrollment
53
Registry id
NCT03703856
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.